| Trial name or title |
Clinical trial of coenzyme Q10 and lisinopril in muscular dystrophies |
| Methods |
Randomised, factorial assignment, open‐label, phase 2 or 3 trial |
| Participants |
120 participants aged 8 and above with DMD, BMD, or autosomal recessive limb‐girdle muscular dystrophy (specifically 2C‐2F and 2I) without clinical cardiac symptoms |
| Interventions |
Participants randomised to 1 of 4 arms: coenzyme Q10 alone, lisinopril alone, coenzyme Q10 and lisinopril, or no study medication |
| Outcomes |
Primary outcome: myocardial performance index (time frame: every 6 months) |
| Starting date |
February 2010 |
| Contact information |
Cooperative International Neuromuscular Research Group |
| Notes |
|
